Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

8.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.1K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

7.9K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
7.9K
The Proteasome02:18

The Proteasome

9.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.5K
The Proteasome01:13

The Proteasome

1.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.3K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

4.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.7K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

13.5K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
13.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thymic cortical epithelial Psmb11-encoded β5t in mouse and human.

International immunology·2026
Same author

Localization of p210 BCR-ABL to the Mitochondria Promotes Chronic Myeloid Leukemia Cell Proliferation Through cIAP Signaling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

The homozygous founder Psmb8 variant of Nakajo-Nishimura syndrome/proteasome-associated autoinflammatory syndrome causes panniculitis-associated lipoatrophy and a shortened lifespan in mice.

Scientific reports·2026
Same author

Proteasome alteration between epithelial and hematopoietic cells facilitates positive selection of CD8 T cells.

Nature communications·2026
Same author

International Symposium on Protein and Organelle Lifetime Regulation (ISPO2025): From Turnover Mechanisms to Targeted Control.

Genes to cells : devoted to molecular & cellular mechanisms·2026
Same author

BRCA1 deficiency leads to aberrant epithelial differentiation in the thymus.

ImmunoHorizons·2025

Related Experiment Video

Updated: Nov 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.6K

Gluing Proteins for Targeted Degradation.

Mikihiko Naito1, Shigeo Murata2

  • 1Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan; National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.

Cancer Cell
|January 12, 2021
PubMed
Summary
This summary is machine-generated.

Targeted protein degradation is a new drug development strategy. A novel mechanism uses small molecules to induce polymerization of the BCL6 oncogenic factor, triggering protein degradation.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.4K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.0K

Related Experiment Videos

Last Updated: Nov 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.6K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.4K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.0K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Targeted protein degradation is a promising therapeutic modality.
  • The oncogenic transcription factor BCL6 plays a role in various cancers.
  • Developing novel strategies for targeted protein degradation is crucial for advancing drug development.

Purpose of the Study:

  • To investigate a novel mechanism for targeted protein degradation.
  • To explore the role of small-molecule-induced polymerization in protein degradation.
  • To target the oncogenic transcription factor BCL6 for degradation.

Main Methods:

  • Utilized small molecules to induce polymerization.
  • Investigated the polymerization of BCL6.
  • Assessed the resulting protein degradation.
  • Published findings in Nature.

Main Results:

  • A novel mechanism of targeted protein degradation was identified.
  • Small-molecule-induced polymerization of BCL6 triggers degradation.
  • This approach offers a new strategy for targeting oncogenic proteins.

Conclusions:

  • Small-molecule-induced polymerization is a viable strategy for targeted protein degradation.
  • BCL6 can be effectively degraded through this novel mechanism.
  • This research opens new avenues for cancer drug development targeting BCL6.